David A. Siegel Sensus Healthcare, Inc. Transaction History

Two Sigma Advisers, LP

$43.8 Billion
Q2 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Sensus Healthcare, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 166,100 shares of SRTS stock, worth $1.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

166,100

Previous 80,700 105.82%

Holding current value

$1.1 Million

Previous $306,000 189.22%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$3.14 - $6.42 $268,156 - $548,268	85,400 Added 105.82%	166,100 $885,000
Q1 2024 May 15, 2024	SELL	$2.49 - $4.91 $19,422 - $38,298	-7,800 Reduced 8.81%	80,700 $306,000
Q4 2023 Feb 14, 2024	SELL	$1.87 - $2.71 $29,920 - $43,360	-16,000 Reduced 15.31%	88,500 $208,000
Q3 2023 Nov 14, 2023	BUY	$2.62 - $3.91 $88,556 - $132,158	33,800 Added 47.81%	104,500 $289,000
Q2 2023 Aug 14, 2023	BUY	$2.62 - $5.28 $91,962 - $185,328	35,100 Added 98.6%	70,700 $222,000
Q1 2023 May 15, 2023	BUY	$4.9 - $9.49 $16,170 - $31,317	3,300 Added 10.22%	35,600 $185,000
Q4 2022 Feb 14, 2023	BUY	$5.91 - $14.28 $12,411 - $29,988	2,100 Added 6.95%	32,300 $239,000
Q3 2022 Nov 14, 2022	BUY	$7.64 - $14.97 $38,964 - $76,347	5,100 Added 20.32%	30,200 $378,000
Q2 2022 Aug 15, 2022	SELL	$7.06 - $11.37 $183,560 - $295,620	-26,000 Reduced 50.88%	25,100 $193,000
Q1 2022 May 16, 2022	BUY	$6.83 - $11.84 $118,159 - $204,832	17,300 Added 51.18%	51,100 $517,000
Q4 2021 Feb 14, 2022	BUY	$3.59 - $8.34 $121,342 - $281,892	33,800 New	33,800 $244,000

Others Institutions Holding SRTS

# of Institutions

Shares Held

3.3M

Call Options Held

600

Put Options Held

View Full List

About Sensus Healthcare, Inc.

Ticker SRTS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 16,556,000
Market Cap $110M
Description
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provide...

More about SRTS

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account